Nafcillin Injection and Pirtobrutinib: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Nafcillin Injection
Pirtobrutinib
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Reduced pirtobrutinib exposure and reduced efficacy of pirtobrutinib
Interaction Deep Dive
Avoid concomitant use of pirtobrutinib with moderate CYP3A inducers. Concomitant use of pirtobrutinib with moderate CYP3A inducers reduces pirtobrutinib exposure which may reduce the efficacy of pirtobrutinib. If concomitant use of a moderate CYP3A inducer is unavoidable, increase the pirtobrutinib dosage. If the current dosage of pirtobrutinib is 200 mg once daily, increase the dose to 300 mg. If the current dosage is 50 mg or 100 mg once daily, increase the dose by 50 mg. Efavirenz and bosentan are predicted to decrease the AUC of pirtobrutinib by 49% and 27% respectively1.
Why it happens (mechanism)
Induction of CYP3A-mediated metabolism of pirtobrutinib
Literature reports
1 report — tap to read
a) Efavirenz and bosentan (moderate CYP3A inducers) are predicted to decrease the AUC of pirtobrutinib by 49% and 27% respectively 1.
Common questions
Can I take Nafcillin Injection and Pirtobrutinib together?
Reduced pirtobrutinib exposure and reduced efficacy of pirtobrutinib Always confirm with your pharmacist or prescriber before making any change.
How serious is the Nafcillin Injection and Pirtobrutinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Questions for your pharmacist
- Does my dose of Nafcillin Injection or Pirtobrutinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: JAYPIRCA(TM) oral tablets, pirtobrutinib oral tablets. Lilly USA LLC (per FDA), Indianapolis, IN, 2023. DailyMed
Keep reading about Nafcillin Injection
Keep reading about Pirtobrutinib
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist